These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3904867)

  • 21. Anti-thymocyte globulin treatment of marrow aplasia associated with paroxysmal nocturnal haemoglobinuria (PNH) resulted in haematological improvement due to an expansion of the PNH clone.
    Cheung WC; Lam CC; Kwong YL
    Br J Haematol; 2003 Jan; 120(2):325-8. PubMed ID: 12542494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stem cell transplantation for paroxysmal nocturnal hemoglobinuria].
    Cermák J; Vítek A; Marinov I; Písacka M; Brabec V
    Vnitr Lek; 2000 Jun; 46(6):319-22. PubMed ID: 15645835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
    Hegenbart U; Niederwieser D; Forman S; Holler E; Leiblein S; Johnston L; Pönisch W; Epner E; Witherspoon R; Blume K; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):689-97. PubMed ID: 14652852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
    Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria.
    Du Y; Han B
    Transplant Cell Ther; 2021 Apr; 27(4):301-307. PubMed ID: 33840442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical hematopoietic stem cell transplant in paroxysmal nocturnal hemoglobinuria.
    Tian H; Liu L; Chen J; Xu Y; Jin Z; Miao M; Fu Z; Qiu H; Sun A; Wu D
    Leuk Lymphoma; 2016; 57(4):835-41. PubMed ID: 26911378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
    Rizk S; Ibrahim IY; Mansour IM; Kandil D
    J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the mutant stem cells have a survival advantage.
    Endo M; Beatty PG; Vreeke TM; Wittwer CT; Singh SP; Parker CJ
    Blood; 1996 Jul; 88(2):742-50. PubMed ID: 8695823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful allogeneic bone marrow retransplantation with the same donor after graft rejection: application of a modified conditioning regimen.
    Gmür J; Frick PG; von Felten A
    Blut; 1979 Jul; 39(1):47-52. PubMed ID: 380689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Nakamura Y; Takenaka K; Yamazaki H; Onishi Y; Ozawa Y; Ikegame K; Matsuoka KI; Toubai T; Ueda Y; Kanda Y; Ichinohe T; Atsuta Y; Mori T
    Int J Hematol; 2021 Jan; 113(1):122-127. PubMed ID: 32889696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
    Srinivasan R; Takahashi Y; McCoy JP; Espinoza-Delgado I; Dorrance C; Igarashi T; Lundqvist A; Barrett AJ; Young NS; Geller N; Childs RW
    Br J Haematol; 2006 May; 133(3):305-14. PubMed ID: 16643433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria.
    Nafa K; Bessler M; Deeg HJ; Luzzatto L
    Blood; 1998 Nov; 92(9):3422-7. PubMed ID: 9787183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ex vivo expansion and clonal variation of CD34(+)CD59(+) cells from bone marrow in children with paroxysmal nocturnal hemoglobinuria].
    Xiao J; Wu YJ; Han B; Dong HY; Chen SP
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):627-32. PubMed ID: 23965874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.
    Takahashi Y; McCoy JP; Carvallo C; Rivera C; Igarashi T; Srinivasan R; Young NS; Childs RW
    Blood; 2004 Feb; 103(4):1383-90. PubMed ID: 14525787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression.
    Nissen C; Tichelli A; Gratwohl A; Warthmann C; Moser Y; dalle Carbonare V; Sendelov S; Chklovskaia E; Jansen W; Wodnar-Filipowicz A; Sadallah S; Speck B
    Acta Haematol; 1999; 101(4):165-72. PubMed ID: 10436296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study.
    Liu L; Liu S; Zhang Y; Zhou H; Wang Q; Tian H; Chen F; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Wu D
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1544-1549. PubMed ID: 30853571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.